Literature DB >> 8893670

Assisted reproductive technology in the United States and Canada: 1994 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry.

.   

Abstract

OBJECTIVE: To summarize the procedures and outcomes of assisted reproductive technology (ART) initiated in the United States in 1994.
DESIGN: Data were collected on the Society for Assisted Reproductive Technology (SART) Database program and submitted to KMPG Peat Marwick, who served as the 1994 collection center for the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. PARTICIPANT(S): Two hundred forty-nine programs submitted data on procedures performed in 1994. Data were collected after October 1995 so that outcome of all pregnancies established would be known. MAIN OUTCOME MEASURE(S): The outcomes measured included clinical pregnancy, ectopic pregnancy, abortion, stillbirth, delivery, and congenital abnormality. RESULT(S): Programs reported initiations of 39,390 cycles of ART treatment, excluding frozen embryo and donor oocyte cycles. Of these, 33,700 cycles initiated were IVF (standard, with micromanipulation, and for host uterus transfer) with 20.7% deliveries per retrieval; 4,214 were cycles of GIFT with 28.4% deliveries per retrieval; 926 were cycles of zygote intrafallopian transfer with 29.1% deliveries per retrieval; and 550 were combination cycles, combining IVF and one of the tubal transfer techniques, resulting in 29.7% deliveries per retrieval. In addition to these cycles initiated in 1994, 7,046 frozen ET procedures were reported, either as separate procedures or in combination with another ART procedure with 15.4% deliveries per procedure, and 3,119 donor oocyte cycles were initiated with an overall success of 46.8% deliveries per retrieval. As a result of all procedures, a total of 9,573 deliveries were reported. CONCLUSION(S): In 1994, there were fewer programs reporting a similar number of treatment cycles of ART as in 1993. Overall average success rates (deliveries per procedures) exhibited only a small increase compared with previously reported summaries.

Entities:  

Mesh:

Year:  1996        PMID: 8893670     DOI: 10.1016/s0015-0282(16)58621-x

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  The effect of hydrosalpinges on IVF-ET outcome.

Authors:  L I Barmat; E Rauch; S Spandorfer; A Kowalik; E S Sills; G Schattman; H C Liu; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  1999-08       Impact factor: 3.412

Review 2.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

3.  Comparison of cryopreservation outcome following intracytoplasmic sperm injection and conventional in vitro fertilization.

Authors:  A Simon; H Holzer; A Hurwitz; A Revel; B S Zentner; F Lossos; N Laufer
Journal:  J Assist Reprod Genet       Date:  1998-08       Impact factor: 3.412

Review 4.  Advances in the evaluation and treatment of the infertile man.

Authors:  E D Kim; L I Lipshultz
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

5.  Assisted hatching reduces the age-related decline in IVF outcome in women younger than age 43 without increasing miscarriage or monozygotic twinning.

Authors:  D R Meldrum; A Wisot; B Yee; G Garzo; L Yeo; F Hamilton
Journal:  J Assist Reprod Genet       Date:  1998-08       Impact factor: 3.412

Review 6.  Untapped Reserves: Controlling Primordial Follicle Growth Activation.

Authors:  Amanda Kallen; Alex J Polotsky; Joshua Johnson
Journal:  Trends Mol Med       Date:  2018-02-13       Impact factor: 11.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.